ENTITY
MicroTech Medical (Hangzhou)

MicroTech Medical (Hangzhou) (2235 HK)

16
Analysis
Information Technology • China
MicroTech Medical (Hangzhou) Co., Ltd. is a Chinese company specializing in the research, development, manufacturing, and commercialization of medical devices and consumables for diabetes management. Its key products include blood glucose monitoring systems (BGMS), continuous glucose monitoring systems (CGMS), and insulin pump systems. The company was founded in 2011 and is headquartered in Hangzhou, China.
more
•18 Oct 2021 13:50

MicroTech (微泰医疗) IPO Trading: Rich Valuation Outweigh Selling Point

We reviewed the latest update prior to trading tomorrow and re-iterate our view that the valuation of MicroTech is rich for its products and expect...

Logo
486 Views
Share
•10 Oct 2021 10:23

ECM Weekly (10th October 2021) - Japan Post, MicroPort Medbot, MicroTech, FWD, Medbanks, 4Paradigm

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Logo
588 Views
Share
•07 Oct 2021 23:50

MicroTech Medical IPO: Valuation Insights

Our valuation analysis suggests that the IPO price range is full and we would remain on the sidelines awaiting a better entry opportunity.

Logo
494 Views
Share
•07 Oct 2021 20:42

MicroTech Medical IPO: Forecasts and Valuation

Our DCF and relative valuation suggests that MicroTech's shares are expensive at the IPO price range. Company is also facing intense competition...

Share
•06 Oct 2021 23:47

MicroTech Medical IPO Initiation: Fighting Diabetes

Microtech has launched an HKEx IPO to raise net proceeds of $225 m. Microtech has three categories of commercialised products and is worth a look at.

Logo
383 Views
Share
x